cell transcriptome analysis (Caris Life Sciences)
Structured Review
Cell Transcriptome Analysis, supplied by Caris Life Sciences, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/transcriptomic+analysis/analysis+cell+transcriptome/pm42236117-276-4-25
Average 86 stars, based on 1 article reviews
Images
Related Articles
other:Article Title: Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis. Article Snippet: Background: The prognostic differences between HER2-zero and HER2-low breast cancer (BC) remain unclear.. Purpose of this meta-analysis is to investigate the differences between HER2-low and HER2-zero in terms of clinicopathological factors and survival outcomes in early-stage BC.. Methods: We searched major databases and congress proceedings until November 1, 2022 to identify studies comparing HER2-zero and HER2-low in early-stage BC. |
